U.S. Drug Price Hikes and Global Health Adjustments
Published on: Jan. 1, 2026, 2:27 a.m. | Source: Devdiscourse
Despite pressure from the Trump administration, drugmakers are set to hike U.S. prices on 350 medications, including vaccines and cancer treatments. Meanwhile, Novo Nordisk and Eli Lilly reduce prices of obesity medications in China. The FDA approves a new motion sickness drug, while the court supports cuts to Planned Parenthood Medicaid funding.
